Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7

general

Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Supraglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Glottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N3: Metastasis in a lymph node, mo

69

Centers

73

Active Trials

$1.1B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7(69)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.5
270.5
3
NCI Comprehensive
High-Volume Research Center
70.5
4
NCI Comprehensive
High-Volume Research Center
70.5
5
NCI Comprehensive
High-Volume Research Center
70.5
6
NCI Comprehensive
High-Volume Research Center
70.5
7
NCI Comprehensive
High-Volume Research Center
70.5
8
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
High-Volume Research Center
70.5
9
NCI Comprehensive
Active Research Program
48.0
10
NCI Comprehensive
Active Research Program
48.0
11
NCI Comprehensive
Active Research Program
48.0
12
NCI Comprehensive
Active Research Program
48.0
13
NCI Comprehensive
Active Research Program
48.0
14
NCI Comprehensive
Active Research Program
48.0
15
NCI Comprehensive
Active Research Program
48.0
16
NCI Comprehensive
Active Research Program
48.0
17
NCI Comprehensive
Active Research Program
48.0
18
NCI Comprehensive
Active Research Program
48.0
19
NCI Comprehensive
Active Research Program
48.0
20
NCI Comprehensive
Active Research Program
48.0
21
NCI Comprehensive
Active Research Program
48.0
22
NCI Comprehensive
Active Research Program
48.0
23
NCI Comprehensive
Active Research Program
48.0
24
NCI Comprehensive
Active Research Program
48.0
25
NCI Comprehensive
Active Research Program
48.0
26
NCI Comprehensive
Active Research Program
48.0
27
NCI Comprehensive
Active Research Program
48.0
28
NCI Comprehensive
Active Research Program
48.0
29
NCI Comprehensive
Active Research Program
48.0
30
NCI Comprehensive
Active Research Program
48.0
31
NCI Comprehensive
Active Research Program
48.0
32
NCI Clinical
Active Research Program
48.0
33
NCI Comprehensive
Active Research Program
48.0
34
Active Research Program
48.0
35
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
48.0
36
NCI Comprehensive
Active Research Program
48.0
37
NCI Clinical
Active Research Program
48.0
38
Active Research Program
48.0
39
NCI Comprehensive
Active Research Program
48.0
40
NCI Comprehensive
Active Research Program
48.0
41
NCI Clinical
Active Research Program
48.0
42
NCI Comprehensive
Active Research Program
48.0
43
NCI Comprehensive
Active Research Program
48.0
44
Active Research Program
48.0
45
NCI Clinical
Active Research Program
48.0
46
NCI Comprehensive
Active Research Program
48.0
47
Active Research Program
48.0
48
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
48.0
49
Active Research Program
48.0
50
NCI Comprehensive
Active Research Program
48.0
5148.0
52
Active Research Program
48.0
53
Active Research Program
48.0
54
Active Research Program
48.0
55
Active Research Program
48.0
56
Active Research Program
48.0
57
Active Research Program
48.0
58
Active Research Program
48.0
59
Active Research Program
48.0
60
Active Research Program
48.0
61
Active Research Program
48.0
62
Active Research Program
48.0
63
Active Research Program
48.0
64
Active Research Program
48.0
65
Active Research Program
48.0
66
NCI Comprehensive
67
NCI Comprehensive
68
69
BC CancerVancouver, BC

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →